Device history record (dhr) review found no discrepancies or anomalies relevant to the complaint.Incoming records review for bupivacaine and lidocaine including the certificates of analysis, provided by the supplier, revealed no discrepancies that may have contributed to a complaint of this nature.Assay testing, performed by the supplier, was within specification for the drug lot number(s) relevant to this complaint.This remediation mdr was generated under protocol (b)(4), as a result of warning letter cms# (b)(4).
|